3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
4
Completed
4
Unknown
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Breast
10
Gastrointestinal
6
Thoracic
4
Lymphoid
3
Other
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
1045
Lung Neoplasms
803
Small Cell Lung Carcinoma
193
Breast Neoplasms
158
Colorectal Neoplasms
157
Neoplasms
128
Melanoma
116
Ovarian Neoplasms
111
Pancreatic Neoplasms
107
Stomach Neoplasms
95
Neoplasm Metastasis
89
Esophageal Neoplasms
77
Squamous Cell Carcinoma of Head and Neck
75
Prostatic Neoplasms
66
Uterine Cervical Neoplasms
65
Head and Neck Neoplasms
65
Endometrial Neoplasms
61
Triple Negative Breast Neoplasms
59
Colonic Neoplasms
58
Carcinoma, Renal Cell
58
Mesothelioma, Malignant
48
Adenocarcinoma of Lung
48
Urinary Bladder Neoplasms
47
Carcinoma, Hepatocellular
46
Mesothelioma
42
Sarcoma
40
Brain Neoplasms
40
Liver Neoplasms
38
Disease
34
NSCLC
33
Interventions
palbociclib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Recruiting
×
Inflammation
×
Thoracic
×
Clear all
NCT07384897
2026-02-03
IMMUNOPUMON2
Université Catholique de Louvain
Phase NA
Recruiting
425 enrolled
NCT07189806
2025-09-24
MAPLE-UK
Hvivo
Recruiting
250 enrolled
NCT07004868
2025-08-11
LCab
University Hospital, Tours
Recruiting
150 enrolled
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled